YULIASTIANI, - and Junaidi Khotib, - and Bambang Subakti Zulkarnain, - (2006) Strategi Terapi Obat Antiretroyiral Dan Anti infeksi Penderita Hiy/Aids Berdasarkan Data Pemeriksaan Cd4 T Limpfosit. Laporan Penelitian. Lembaga Penelitian Dan Pengabdian Kepada Masyarakat Universitas Airlangga, Surabaya. (Unpublished)

Text 2022_03_25_15_11_42.pdf Download (4MB)

Abstract

The pwposes of this study were to evaluate and to analyze the antiretroviraI (ARV) utilization in mY/AIDS patients who were hospitalized during January 1 st, 2004 until January 1st , 2006 at Deparbnent of Infection Disease Intennediet Cure-Dr. Soetomo General Hospital Surabaya. This study used descriptively analysis by using retrospective data from patient's medical record. The results showed that ARV which most used was the fIrst line included lamiwdinel3TC (32,62%), zidovudinel AZT (32,09%), nevirapineINVP (30,48%)%) and the combination which mostly used was zidowdin + lamiwdin + nevirapin (82,43%). The major antimicrobial prescribing were cotrimoxazole (13,40%), ceftriaxon (10,14%), levofloxacin (7,61%) dan antifungi: nistatine (11,23%), ketoconazole (7,61%), fluconazole (6,88%). From this study, over 90% patients confonned to WHO guidelines (ARV was recommended to patient Stage m and IV based on the levels of CD4+ T Lymphocytes count). There were 20% patient which changing or stopping ARV because adverse drug reaction.

Actions (login required)

View Item